• Explore /
  • Poster
  • / Observational cohort study of first-line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Sub-group analysis by KRAS Exon2 status.

Observational cohort study of first-line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Sub-group analysis by KRAS Exon2 status.

Abstract Poster

Authors

null

Takenori Takahata

Department of Medical Oncology, Hirosaki University, Graduate School of Medicine, Hirosaki, Japan

Takenori Takahata , Satoshi Yuki , Hiroshi Nakatsumi , Kazuaki Harada , Hiraku Fukushima , Atsushi Sato , Takashi Kato , Takashi Meguro , Michio Nakamura , Nobuyuki Ehira , Ichiro Iwanaga , Miki Tateyama , Kazuteru Hatanaka , Kazunori Eto , Hiroyuki Okuda , Yoshimitsu Kobayashi , Osamu Muto , Masakazu Abe , Yuh Sakata , Yoshito Komatsu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 782)

DOI

10.1200/jco.2015.33.3_suppl.782

Abstract #

782

Poster Bd #

F20

Abstract Disclosures

Similar Posters

First Author: Michio Nakamura

First Author: Kazuteru Hatanaka

First Author: Keisei Taku

First Author: Pilar Garcia-Alfonso